Among 147 people treated with Piqray, more than 80% developed high blood sugar (hyperglycemia), and about 40% developed serious hyperglycemia. Photo by peejhunt/Pixabay For certain patients with ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer after CDK4/6 inhibitor treatment. The EPIK-B5 study reported a median ...
Piqray (alpelisib, formerly BYL719) plus fulvestrant nearly doubled median PFS (11.0 vs 5.7 months) in HR+/HER2- advanced breast cancer patients with a PIK3CA mutation compared to fulvestrant alone in ...
New data underscore efficacy of Piqray, even in those patients with a short treatment duration on prior CDK4/6i or with ESR1 mutations, biomarkers of endocrine resistance[1-5] Recent guideline updates ...
Novartis’ promise of 25 potential blockbuster launches is steadily coming to fruition. On the same day the FDA approved gene therapy Zolgensma, the U.S. regulator also waved through breast cancer drug ...
Piqray led to elevated blood sugar in many patients with breast cancer, a recent research showed. Patients with breast cancer who were being treated with Piqray (alpelisib) showed increased high blood ...
Piqray brought in sales of $79 million in the second quarter of this year, up from $74 million in the previous quarter. The European Commission approved Piqray in July, and analysts are expecting ...
Novartis has moved nearer to claiming approval for its PI3K inhibitor Piqray for breast cancer in the EU, one of a crop of new drugs that the company thinks have blockbuster sales potential. The EMA’s ...
For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels. "This ...
Add Yahoo as a preferred source to see more of our stories on Google. Among 147 people treated with Piqray, more than 80% developed high blood sugar (hyperglycemia), and about 40% developed serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results